AstraZeneca Vaccine Fails to Protect Against the South African Variant
forbes.com
forbes.com
Furthermore, it doesn't include any information about hospitalisations/deaths caused by covid in the vaccinated group, most likely due to the small sample - 1000, but still an integral part of any piece claiming good/bad efficiency of vaccines. So this piece did not provide any value to me.
Trials for the AstraZeneca vaccine began in July. The South African variant was detected in October and reported only in December...